Press release
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
Mr. Leach begins his inaugural year as CEO with speaking engagements at CES 2026 and the 44th annual J.P. Morgan Healthcare Conference A completely
About this update from Dexcom, Inc.
[{"type":"text","content":"\n\nMr. Leach begins his inaugural year as CEO with speaking engagements at CES 2026 and the 44th annual J.P. Morgan Healthcare Conference\n\n\n\nA completely reimagined Stelo app experience will launch this year, further advancing personalized health technology for consumers interested in metabolic health\n\n\n\nWith continued investments across its portfolio, including the pharmacy launch of Dexcom G7 15 Day and AI-driven enhanced features, Dexcom is poised to transform even more lives through its glucose biosensing technology in 2026\n\n\n\n SAN DIEGO--(BUSINESS WIRE)--\nDexCom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his expanded responsibilities on Jan. 1.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107580853/en/The daily tab highlights a user’s current and recent glucose readings, their time in range, logged events and insights.\n“I’ve had the honor of playing a role in shaping Dexcom’s industry-defining innovation since joining the company more than 20 years ago. From building the technology as an engineer in my early days, to advancing global scale to meet our long-term growth demand as COO, it’s an honor to step into the role of CEO during such a pivotal moment for the business—and a growing global metabolic health crisis,” said Jake Leach. “I look forward to further advancing Dexcom’s long legacy of empowering people to take control of health.”\n\n\nMr. Leach's tenure commences with prominent appearances that underscore Dexcom's leadership in biosensing innovation. His first public engagement as CEO will occur at CES 2026 on Jan. 7, where he will join a mainstage panel alongside leaders from Dexcom partners ŌURA and Rimidi examining the revolutionary impact of continuous health monitoring for users, clinicians and the healthcare system at large.\n\n\nSubsequently, Mr. Leach will deliver the opening presentation at the 44th Annual J.P. Morgan Healthcare Conference on Jan. 12 at 7:30 A.M. PT, where he will present his vision for Dexcom and outline key milestones to expect in 2026.\n\n\nDuring these upcoming events, Mr. Leach will share the transformational updates taking place across Dexcom’s ...